NEXT GENERATION PEPTIDE DRUGS FAVOR SYNTHETIC, NOT RECOMBINANT MANUFACTURING
Peptide manufacturing for commercial-scale production primarily employs two main methodologies: synthetic and recombinant. Each method presents unique advantages and challenges, crucial for stakeholders in the pharmaceutical industry to consider when…
Supporting Save the Children Finland: Orion’s Donation Ensures No Child or Young Person Copes Alone
The rising cost of living compounds the difficulties faced by low-income families with children, creating an urgent need for support, says Heidi Herranen, Coordinator of Save the Children Finland’s Fuel…
Cerevel Therapeutics Reports Favorable Topline Findings in Phase 3 Adjunctive Study of Tavapadon for Parkinson’s Disease Patients
Cerevel Therapeutics (Nasdaq: CERE) has released encouraging findings from its pivotal Phase 3 TEMPO-3 trial for tavapadon, a unique D1/D5 receptor partial agonist investigated as a once-daily treatment for Parkinson’s…
WHO Grants Prequalification to Innovative Oral Cholera Vaccine
A new oral vaccine for cholera has received prequalification by the World Health Organization (WHO) on 12 April. The inactivated oral vaccine Euvichol-S has a similar efficacy to existing vaccines…
Debut of WHO’s Patient Safety Rights Charter Marks Milestone in Healthcare
Today marked a significant milestone in healthcare as the World Health Organization (WHO) unveiled the Patient Safety Rights Charter during the Global Ministerial Summit on Patient Safety. This groundbreaking Charter,…
Updated Terminology for Airborne Pathogens Released by Leading Health Agencies
In collaboration with public health agencies and experts worldwide, the World Health Organization (WHO) has released a comprehensive report introducing updated terminology for pathogens transmitted through the air. The report,…
NEXT GENERATION PEPTIDE DRUGS FAVOR SYNTHETIC, NOT RECOMBINANT MANUFACTURING
The advent of new drugs targeting diabetes, obesity, and cardiovascular diseases has sparked a surge in the demand for polypeptide manufacturing. This surge, in turn, has propelled an industrial intensification…
Report on Results from ICMRA-WHO Workshop Addressing Strain Changes in COVID-19 Vaccines
Today, the joint effort of the International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization (WHO) culminated in the publication of a comprehensive report detailing the outcomes…
FINTLEPLA®▼ (fenfluramine) oral solution gains approval in Japan as adjunctive therapy for seizures linked with Lennox-Gastaut syndrome (LGS)
UCB’s FINTEPLA®▼ (fenfluramine) oral solution has received approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for treating seizures linked with Lennox-Gastaut syndrome (LGS) as an additional therapy…
Merck Sparks Curiosity: 2024 STEM Careers Exploration Tour with the Curiosity Cube
Merck’s Curiosity Cube Hits the Road: Inspiring 45,000 Students Across 14 Countries Merck, a global leader in science and technology, has launched its 2024 Curiosity Cube tour from Darmstadt, Germany,…
Jumar Bioincubator Launches Mission: Crafting Australia’s Future CSL with Mini-Brains and Lab-on-a-Chip Wearables
Australia’s Latest Biotech Incubator, Jumar Bioincubator, Unveils First Cohort of Innovative Ventures Melbourne, Australia – Jumar Bioincubator, the newest addition to Australia’s biotech landscape, has officially opened its doors, showcasing…
48-Week Phase 2 Frexalimab Data Shows Promising, Sustained Efficacy in MS
Sanofi’s frexalimab, a CD40L antibody, has displayed enduring effectiveness and favorable tolerability over almost a year in individuals with relapsing multiple sclerosis (MS). These findings will be unveiled today at…